PHÂN TÍCH TÌNH HÌNH SỬ DỤNG INSULIN VÀ NHÓM THUỐC HẠ ĐƯỜNG HUYẾT TRONG ĐIỀU TRỊ NGOẠI TRÚ CÓ BẢO HIỂM Y TẾ TẠI BỆNH VIỆN LÊ VĂN THỊNH NĂM 2021

Abstract

Objectives: This study was conducted to analyze the use of insulin and hypoglycemic drugs for diabetes outpatient with health insurance at Le Van Thinh Hospital in 2021. Materials and methods: A cross-sectional descriptive study at Le Van Thinh Hospital in 2021 reviewed insulin and other hypoglycemic medication lists and expenditures among diabetic outpatients with health insurance. Results: In 2021, Le Van Thinh Hospital used 126 insulin and hypoglycemic products (corresponding to 52 active ingredients), including 25 insulin products (12 active ingredients) and 101 oral hypoglycemic medications (40 active ingredients). Insulin products accounted for 19.8% of the total number of studied products. 126 products were from 14 countries, 29 from domestic manufacture and 97 from import, accounting for 23.0% and 77.0%, respectively. Brand products accounted for 40.5% of the study products. Total expenditures totaled 21.4 billion VND, including 28.5% for insulin, 20.0% for domestic products, and 34.9% for brand products. Conclusion: Diabetes outpatients with health insurance at Le Van Thinh hospital were mainly treated with insulin and hypoglycemic products in 2021. Based on the results of the study, the hospital can adjust the types and quantities of active ingredients for procurement in the coming years.